Cardiovascular imaging to quantify the evolution of cardiac diseases in clinical development

Area of Science:

• Cardiology
• Medical Imaging
• Quantitative Analysis

Background:

• Cardiovascular diseases are a primary cause of mortality in Western countries.
• Medical imaging is crucial for evaluating cardiac perfusion and function, aiding treatment assessment.
• Assessing disease progression and treatment efficacy in clinical trials requires robust imaging methods.

Purpose of the Study:

• To review diverse medical imaging modalities for evaluating cardiovascular disease evolution, particularly coronary artery disease.
• To examine advanced techniques like image co-registration and population modeling for quantitative cardiac assessment.
• To compare the advantages and disadvantages of various imaging techniques in clinical trials.

Main Methods:

• Review of established and emerging medical imaging modalities.
• Analysis of image co-registration and population modeling techniques.
• Comparative assessment of Gated/Tagged MRI, MRI for perfusion, PET, SPECT, Gated SPECT, MUGA, and Ultrasound.

Main Results:

• Detailed comparison of imaging modalities for cardiac perfusion and function assessment.
• Highlighting the utility of quantitative SPECT and its recent advancements.
• Identification of pros and cons for each modality in clinical trial settings.

Conclusions:

• Medical imaging plays a vital role in managing cardiovascular diseases and assessing treatment outcomes.
• Quantitative analysis using advanced imaging techniques enhances diagnostic accuracy.
• The choice of imaging modality depends on specific clinical trial objectives and patient populations.